We are live on ! Find out more
CLRB icon

Cellectar Biosciences
CLRB

39 hedge funds and large institutions have $36.9M invested in Cellectar Biosciences in 2020 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

762% more capital invested

Capital invested by funds: $4.28M → $36.9M (+$32.6M)

333% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 6

150% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 2

95% more funds holding

Funds holding: 20 → 39 (+19)

0.09% more ownership

Funds ownership: 0.04% → 0.13% (+0.09%)

Holders
39
Holders Change
+19
Holders Change %
+95%
% of All Funds
0.69%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
26
Increased
5
Reduced
2
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
CCM
Consonance Capital Management
New York
+$6.24M
2
MS
Maven Securities
Jersey
+$2.64M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$2.21M
4
SCM
Sio Capital Management
New York
+$1.48M
5
6CM
683 Capital Management
New York
+$1.42M

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$261K
2
WVP
Worth Venture Partners
New Jersey
-$218K
3
QP
Quilter Plc
United Kingdom
-$72K
4
WS
Wedbush Securities
California
-$56K
5
Squarepoint
Squarepoint
New York
-$22K
Name Holding Trade Value Shares
Change 		Change in
Stake
Envestnet Asset Management
26
Envestnet Asset Management
Illinois
$26K +$18.8K +41 New
CAM
27
Cozad Asset Management
Illinois
$23K +$17K +37 New
SFS
28
Sowell Financial Services
Arkansas
$22K +$16.5K +36 New
PNC Financial Services Group
29
PNC Financial Services Group
Pennsylvania
$21K – – –
LC
30
Lindbrook Capital
California
$21K +$15.2K +33 New
MWM
31
Modera Wealth Management
New Jersey
$21K +$15.2K +33 New
Osaic Holdings
32
Osaic Holdings
Arizona
$13K -$4.6K -10 -32%
US Bancorp
33
US Bancorp
Minnesota
$6K – – –
Wells Fargo
34
Wells Fargo
California
$6K +$460 +1 +10%
Morgan Stanley
35
Morgan Stanley
New York
$5K – – –
CAPTRUST Financial Advisors
36
CAPTRUST Financial Advisors
North Carolina
$4K +$3.22K +7 New
UBS Group
37
UBS Group
Switzerland
$3K +$2.3K +5 New
SIAG
38
Safeguard Investment Advisory Group
California
$2K +$1.38K +3 New
WVP
39
Worth Venture Partners
New Jersey
– -$218K -585 Closed
QP
40
Quilter Plc
United Kingdom
– -$72K -194 Closed
WS
41
Wedbush Securities
California
– -$56K -149 Closed
Squarepoint
42
Squarepoint
New York
– -$22K -58 Closed
TRCT
43
Tower Research Capital (TRC)
New York
– -$7K -19 Closed
PFS
44
Prospera Financial Services
Texas
– -$1K -3 Closed
1
2

CLRB Hedge Fund Activity: Q4 2020 in Review

39 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Cellectar Biosciences (CLRB) for Q4 2020, worth a combined $36.9M — up 762% from $4.28M a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new CLRB positions and 6 closed out — a net gain of 20 holders — while 5 added to existing stakes and 2 trimmed.

The largest buyer was Consonance Capital Management, opening a new position worth an estimated $6.24M. The largest seller was Renaissance Technologies, cutting an estimated $261K.

  • 39 institutional investors held Cellectar Biosciences (CLRB) as of Q4 2020, up from 20 in Q3 2020.
  • Funds reported $36.9M of Cellectar Biosciences stock for Q4 2020, up 762% quarter-over-quarter.
  • 26 funds opened new Cellectar Biosciences positions in Q4 2020 and 6 closed out, a net change of +20 holders.
  • The largest Cellectar Biosciences buyer in Q4 2020 was Consonance Capital Management, an estimated $6.24M added.
  • The largest Cellectar Biosciences seller in Q4 2020 was Renaissance Technologies, an estimated $261K sold.

Based on aggregated 13F filings for Q4 2020.